Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria (Roswell Park Cancer Institute)
America's oldest cancer center and one of the world's newest oncology centers are partnering to improve access to cancer prevention, screening and care for the people of Nigeria. Roswell Park Cancer Institute (RPCI) and Lakeshore Cancer Center (LCC) have announced an affiliation that will see Roswell Park faculty providing clinical consultations to assist LCC oncologists, who will also have access to both training at RPCI and continuing professional education seminars they can participate in rem... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 30, 2015 Category: Cancer & Oncology Source Type: news

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Targeted Combination Approaches with Afatinib in Lung Cancer
The NCCN Oncology Research Program (ORP) received a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to facilitate studies of afatinib in non-small cell lung cancer. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has been awarded a $2-million grant from Boehringer Ingelheim Pharmaceuticals, Inc. to develop a program to evaluate scientifically targeted combination approaches with afatinib in the treatment of non-small c... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 13, 2015 Category: Cancer & Oncology Source Type: news

NCCN Collaborates with Pfizer to Improve Provider Performance and Quality in Treatment of Metastatic Breast Cancer
NCCN and Pfizer will elicit grant proposals for quality improvement and education in metastatic breast cancer. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects. As part of this program, the N... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 5, 2015 Category: Cancer & Oncology Source Type: news

Oncology Experts to Deliberate Tissue Allocation Issues at Upcoming NCCN Policy Summit
The National Comprehensive Cancer Network® (NCCN®) will host Emerging Issues in Tissue Allocation, on June 8, 2015, at the National Press Club in Washington, DC. FORT WASHINGTON, PA - Tissue allocation is a growing issue of concern for many researchers due, in part, to expanding research interests in precision medicine. The increased demand by pharmaceutical and biotech companies for patient tissue specimens collected for clinical care and trials presents clinical, ethical, and legal issues. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 3, 2015 Category: Cancer & Oncology Source Type: news

Flatiron Health to Incorporate NCCN Chemotherapy Order Templates into OncoEMR
The integration of the NCCN Chemotherapy Order Templates (NCCN Templates®) into the Flatiron Health OncoEMR® electronic health record will allow for access to evidence-based treatment protocols based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is collaborating with Flatiron Health to integrate the NCCN Chemotherapy Order Templates (NCCN Templates®) into the Flatiron Health OncoEMR® electronic... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 20, 2015 Category: Cancer & Oncology Source Type: news

NCCN Receives $2-Million Funding Commitment from ImmunoGen, Inc. to Study Mirvetuximab Soravtansine for Folate Receptor Alpha-Positive Cancers
The NCCN Oncology Research Program (ORP) has received a $2-million grant from ImmunoGen, Inc. to facilitate preclinical and clinical research with mirvetuximab soravtansine for folate receptor alpha-positive cancers at NCCN Member Institutions and their affiliate community hospitals. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has been awarded a $2-million grant from ImmunoGen, Inc. to support the advancement of scientific knowledg... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 17, 2015 Category: Cancer & Oncology Source Type: news

NCCN Foundation
The NCCN Foundation® has awarded its fifth series of Young Investigator Awards to six oncology researchers from NCCN Member Institutions; the awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing and improving outcomes in cancer care. FORT WASHINGTON, PA - The NCCN Foundation®, which, through philanthropy empowers people through knowledge and advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality, eff... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 8, 2015 Category: Cancer & Oncology Source Type: news

NCCN Foundation Awards Grants to Six Young Investigators
The NCCN Foundation® has awarded its fifth series of Young Investigator Awards to six oncology researchers from NCCN Member Institutions; the awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing and improving outcomes in cancer care. FORT WASHINGTON, PA - The NCCN Foundation®, which, through philanthropy empowers people through knowledge and advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality, eff... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 6, 2015 Category: Cancer & Oncology Source Type: news

Final Roundtable of the NCCN 20
The third and final roundtable of the NCCN 20th Annual Conference explored essential elements of clinical practice guidelines, as well as the historical development of the NCCN Guidelines®. FORT WASHINGTON, PA - The third and final roundtable of the National Comprehensive Cancer Network® (NCCN®) 20th Annual Conference: Advancing the Standard of Cancer Care™, What are the Characteristics of an Optimal Clinical Practice Guideline?, was held Saturday, March 14, 2015. Moderated by F. Marc Ste... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 4, 2015 Category: Cancer & Oncology Source Type: news

NCCN Holds Fourth Annual State Oncology Society Forum
The fourth annual state oncology society forum, held in conjunction with NCCN's 20th Annual Conference, examined accountable care, payment reform, and best practices from community oncologists. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) held its fourth annual State Oncology Society Forum during the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™, facilitating discussions about coordinated care under the Affordable Care Act (ACA) and payment re... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 3, 2015 Category: Cancer & Oncology Source Type: news

Highlights from the NCCN 20
Approximately 1,500 oncology representatives attended the NCCN 20th Annual Conference, which featured presentations of the latest developments in the treatment of more than 15 cancer types, as well as three expert roundtable discussions. FORT WASHINGTON, PA - The NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ was hosted by the National Comprehensive Cancer Network® (NCCN®) from March 12 - 14, 2015 at The Diplomat in Hollywood, Florida. During this year's conference, NCCN ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 22, 2015 Category: Cancer & Oncology Source Type: news

NCCN and ECO Collaborate to Translate and Regionally Adapt NCCN Guidelines
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) is collaborating with Foundation for Excellence and Quality in Oncology (ECO) to publish Spanish translations of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), as well as regional adaptions for Spain. NCCN Guidelines® for the following diseases will be translated into Spanish and adapted: Breast, Colorectal, Non-Small Cell Lung (NSCLC), and Prostate Cancers and Melanoma, beginning with NSCLC for use in... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 20, 2015 Category: Cancer & Oncology Source Type: news

Disparities in Defined Value Pose Challenges to Oncology Decision-Makers, Say NCCN Panelists
The second roundtable discussion of the NCCN 20th Annual Conference explored the concept of value in oncology decision-making, challenging the perceived definition of value and true quality for the patient. FORT WASHINGTON, PA - On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care™, the National Comprehensive Cancer Network® (NCCN®) hosted its second roundtable, Value-Based Decision-Making at the Bedside, which reflected on the tools availabl... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 19, 2015 Category: Cancer & Oncology Source Type: news

New NCCN Member Institution: Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute has been named the newest NCCN Member Institution; NCCN now has 26 Member Institutions serving patients throughout the United States. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), an alliance of the world's leading cancer centers dedicated to quality, effectiveness, and efficiency of cancer care so that patients can live better lives, today anno... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 16, 2015 Category: Cancer & Oncology Source Type: news

Preliminary NCCN Guidelines
FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) has published a preliminary version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Global Resource Stratification™: Cervical Cancer; these NCCN Guidelines® are optimized to account for variability in available clinical treatment resources. NCCN Guidelines are used widely around the world, including in a number of regions with low- to mid-level resources. The goal of NCCN Guidelines for Global... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 15, 2015 Category: Cancer & Oncology Source Type: news